BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23291186)

  • 1. Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice.
    Lu J; Cheng H; Atti E; Shih DM; Demer LL; Tintut Y
    Biochem Biophys Res Commun; 2013 Feb; 431(1):19-24. PubMed ID: 23291186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts.
    Li X; Garcia J; Lu J; Iriana S; Kalajzic I; Rowe D; Demer LL; Tintut Y
    J Cell Biochem; 2014 Jan; 115(1):179-88. PubMed ID: 24038594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids.
    Sage AP; Lu J; Atti E; Tetradis S; Ascenzi MG; Adams DJ; Demer LL; Tintut Y
    J Bone Miner Res; 2011 Jun; 26(6):1197-206. PubMed ID: 21611962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia impairs osteoanabolic effects of PTH.
    Huang MS; Lu J; Ivanov Y; Sage AP; Tseng W; Demer LL; Tintut Y
    J Bone Miner Res; 2008 Oct; 23(10):1672-9. PubMed ID: 18505371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L; Quarles LD; Spurney RF
    J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR; Dahlhoff M; Andrukhova O; Grill J; Glösmann M; Schüler C; Weber K; Wolf E; Erben RG
    Bone; 2012 Jan; 50(1):237-44. PubMed ID: 22056328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
    J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
    Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
    J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.
    Jilka RL; Almeida M; Ambrogini E; Han L; Roberson PK; Weinstein RS; Manolagas SC
    Aging Cell; 2010 Oct; 9(5):851-67. PubMed ID: 20698835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.
    Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F
    Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.
    Yuan Q; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
    J Bone Miner Res; 2011 Sep; 26(9):2026-35. PubMed ID: 21590742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
    Clifton KB; Conover CA
    Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anabolic action of intermittent parathyroid hormone on cortical bone depends partly on its ability to induce nitric oxide-mediated vasorelaxation in BALB/c mice.
    Gohin S; Carriero A; Chenu C; Pitsillides AA; Arnett TR; Marenzana M
    Cell Biochem Funct; 2016 Mar; 34(2):52-62. PubMed ID: 26834008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone.
    Saito H; Gasser A; Bolamperti S; Maeda M; Matthies L; Jähn K; Long CL; Schlüter H; Kwiatkowski M; Saini V; Pajevic PD; Bellido T; van Wijnen AJ; Mohammad KS; Guise TA; Taipaleenmäki H; Hesse E
    Nat Commun; 2019 Mar; 10(1):1354. PubMed ID: 30902975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.